BestPractice Nordic DK
VerifiedBestPractice Nordic publishes articles, videos and podcasts with specialty-specific content for doctors, nurses and healthcare professionals in Denmark, Norway, Sweden and Finland. All publications and content are planned and produced in collaboration with independent medical/nursing editorial teams in each specialty and in each country. All articles are written by specialists with special knowledge within their clinical field to ensure proximity and professional relevance. The individual author's assessment does not necessarily reflect the editorial team's views, but solely expresses the writer's own opinions. The goal of BestPractice Nordic is to contribute to the exchange of experience, debate and best practice within each clinical specialty. Source
Actions
Media Outlet details
| Scope | National |
|---|---|
| Language | Danish, English |
| Country | Denmark |
Similarweb UVM
|
Request pricing |
Comscore UVM
|
Request pricing |
Recent Articles
Search ArticlesImmunceller har betydning for prognose efter post-operativ stråleterapi blandt brystkræftpatienter
Skip to Content juli 2026 Immunceller i brystkræfttumorer kan have betydning for patienters prognose efter stråleterapi. I et dansk ph.d.-projekt blev både tumorinfiltrerende lymfocytter (TILs) og specifikke immuncellesubtyper undersøgt i to store Dansk Brystkræftgruppe (DBCG)-patientkohorter. Resultaterne peger på en stærkere association med prognose blandt patienter med østrogenreceptor (ER)-negative tumorer.
Tumor-Associated Macrophages and TNF-α May Help Rescue Treatment Efficacy in Ovarian Cancer
juli 2026 Ricardo Coelho, MD and Senior Postdoctoral Researcher at Universitätsspital Basel, discusses how chemotherapy-induced changes in the tumor microenvironment may be leveraged to improve treatment efficacy in high-grade serous ovarian cancer.
ASCO 2026: Telisotuzumab Adizutecan Shows Promising Activity in Platinum-Resistant Ovarian Cancer
juli 2026 Promising results were observed with telisotuzumab adizutecan (TMAb-A) in patients with platinum-resistant ovarian cancer, with higher response rates seen in tumors with increased c-MET expression. At ASCO 2026, Gini Fleming, Professor of Medicine and Medical Director of Gynecologic Oncology at the University of Chicago, presents the basket trial findings and discusses the next steps in the clinical development of TMAb-A.
EAN 2026: Multiple Sclerosis Affects Social Life Beyond Physical Function
Skip to Content juli 2026 The Italian SocialMS study, presented at the 2026 EAN Congress, found that Multiple Sclerosis significantly affects patients' social lives, close relationships, and other social determinants of health. The findings highlight the importance of addressing the social consequences of MS as part of comprehensive patient care.
EAN 2026: Improving Reference Limits for Nerve Conduction Studies
juli 2026 Tomasz Szczepanski, MD, MSc, PhD, Section for Clinical Neurophysiology, Department of Neurology, Oslo University Hospital, Norway, presented his PhD research on improving reference limits for nerve conduction studies at the EAN 2026 Congress.
EAN 2026: Late Light-Off Response May Predict Recovery of Consciousness After Acute Brain Injury
Skip to Content juli 2026 Data from a Danish study presented at the 2026 EAN Congress suggest that the late light-off response may help identify which patients are likely to improve following an acquired brain injury. Få adgang Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.
EAN 2026: NorMig Evaluates Dual Therapy for Chronic Migraine
juli 2026 The NorMig trial was presented by Burcu Bezgal, Neurologist and PhD Candidate, Department of Neurology, Oslo University Hospital, Norway, at the EAN 2026 Congress. As the first international randomized, placebo-controlled, double-blind phase III trial, NorMig is investigating whether combining a CGRP monoclonal antibody with onabotulinumtoxinA can improve outcomes for patients with chronic migraine who remain symptomatic despite monotherapy.
Spiseforstyrrelser er langt mere end mad, vægt og udseende
Skip to Content juli 2026 Spiseforstyrrelse er en kompleks psykisk lidelse med alvorlige konsekvenser for både den enkelte og de pårørende. I forbindelse med udgivelsen af ’Spiseforstyrrelser – viden, behandling og debat’ fortæller forfatterne Lene Kiib Hecht og Birgitte Hartvig Schousboe om udviklingen på området og om udfordringerne ved at forstå og behandle spiseforstyrrelser.
EAN 2026: Can Pre-Stroke Weight Loss Prevent Persistent Disability in Type 2 Diabetes?
juli 2026 Pre-stroke weight loss, achieved through diet or GLP-1 receptor agonists, may help prevent persistent post-stroke disability in type 2 diabetes, according to experimental findings presented at EAN 2026. Ellen Vercalsteren, postdoctoral researcher at the Karolinska Institute, also discusses why new approaches are needed to improve stroke outcomes in people with type 2 diabetes.
EHA 2026: Acalabrutinib Shows Durable Responses in Frail and Elderly Patients with CLL
juli 2026 Updated results from the CLL-Frail trial presented at EHA 2026 show durable responses, sustained improvements in self-assessed frailty and quality of life, and an overall survival of more than 80% after three years in patients aged 80 years or older or living with frailty. Florian Simon, study physician at the German CLL Study Group, also discusses why honest discussions about treatment goals, benefits, and safety remain essential.